DNMT3B and breast carcinoma: While Cebrian et al. showed that there was a significant difference in genotype distribution between breast cancer patients and controls, with the T allele (variant) associated with a reduced risk for breast cancer[2], our own analyses did not show a statistically significant correlation between the DNMT3B SNP and corresponding clinical parameters.